Actively Recruiting
Risk Evaluation by Coronary Imaging and Artificial Intelligence-Based Functional Analysis Integrated Plaque Analysis Using Coronary CT Angiography and Intracoronary Imaging
Led by Ruijin Hospital · Updated on 2025-01-27
300
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a single-center, prospective study to analyze coronary artery plaque characteristics and local blood flow in patients diagnosed with chronic coronary syndrome (CCS) or non-ST-segment elevation acute coronary syndrome (NSTE-ACS). The study focuses on patients with marginal or obstructive lesions in major coronary arteries, aiming to improve the accuracy of plaque assessment using multiple imaging methods, including coronary CT angiography (CCTA) and intracoronary imaging techniques like intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near infrared spectroscopy (NIRS). The goal is to develop a new CCTA-based model to better identify high-risk plaques. Participants will undergo noninvasive CCTA scans followed by invasive coronary angiography and intracoronary imaging within one month. The study will use advanced methods such as co-registration, feature extraction, radiomic analysis, and machine learning to enhance plaque analysis. The new model will be compared with traditional CTA models to assess its ability to detect high-risk plaques and predict major adverse cardiovascular events. Patients will be followed every three months for two years to monitor outcomes. Researchers will evaluate the agreement between different imaging techniques and track the prediction performance of the new high-risk plaque model over this period. The study includes regular assessments to ensure participant safety and adherence, with the total participation lasting two years.
CONDITIONS
Official Title
Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 218 years
- Diagnosed with chronic coronary syndrome (CCS) or non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
- Underwent coronary CT angiography (CCTA) showing marginal lesions (diameter stenosis between 40%-69%) or obstructive lesions (diameter stenosis 270% or CT-FFR <0.8) in major coronary arteries
- Received invasive coronary angiography and intracoronary imaging (IVUS, OCT, NIRS) within 1 month after CCTA
You will not qualify if you...
- Unsuitable for coronary CT angiography (e.g., severe renal impairment, uncontrolled thyroid condition, allergy to iodine)
- Percutaneous coronary intervention (PCI) within the past 6 months
- Prior history of myocardial infarction or heart failure
- Prior history of coronary artery bypass graft (CABG)
- Abnormal liver function (ALT level exceeding 3 times the upper limit of normal) or abnormal kidney function (eGFR 230%)
- Familial hypercholesterolemia
- Estimated survival of 1 year or less
- Malignant tumor
- Pregnant, breastfeeding, or planning to become pregnant within one year
- Poor compliance or inability to follow up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
X
Xiaoqun Wang, M.D., Ph.D.
S
Shuo Feng, M.D., Ph.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here